Marta Maria Duarte Carvalho Vila

Prof. Dr. Marta Maria Duarte Carvalho Vila


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Microbiological Research
Verified
Journal Article
Closed access
LHLiliam K. Harada
Liliam K. Harada
ESErica C. Silva
Erica C. Silva
WCWelida F. Campos
Welida F. Campos
FFFERNANDO SÁ DEL FIOL
FERNANDO SÁ DEL FIOL
MVMarta Maria Duarte Carvalho Vila
Marta Maria Duarte Carvalho Vila
Victor M. BalcãoVictor M. Balcão
Victor M. Balcão

1 October 2016 in Microbiological Research
Verified
Journal Article
Closed access
ARAlessandra C. Rios
Alessandra C. Rios
CMCarla Moutinho
Carla Moutinho
FPFlávio C. Pinto
Flávio C. Pinto
FFFERNANDO SÁ DEL FIOL
FERNANDO SÁ DEL FIOL
AJAngela Jozala
Angela Jozala
VBVictor M. Balcão
Victor M. Balcão

1 October 2015 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
Victor M. BalcãoVictor M. Balcão
Victor M. Balcão
MVMarta Maria Duarte Carvalho Vila
Marta Maria Duarte Carvalho Vila

1 August 2013 in Food Hydrocolloids
Verified
Journal Article
Open access
Victor M. BalcãoVictor M. Balcão
Victor M. Balcão
CCCarla I. Costa
Carla I. Costa
CMCarla Matos
Carla Matos
CMCarla Moutinho
Carla Moutinho
MAManuela Amorim
Manuela Amorim
José TeixeiraJosé Teixeira
José Teixeira
Lactoferrin has for long captured the interest of many researchers as a natural compound with a wide variety of uses. Lactoferrin is a monomeric, iron-binding 80 kDa glycoprotein, and appears to be the subfraction of whey with the best documented antiviral, antimicrobial, anticancer and immune modulating/enhancing effects. It belongs to the family of transferrin proteins, and serves to control iron levels in body fluids by sequestering and solubilizing ferric iron. In the present research effort, production of lactoferrin derivatives (starting from a purified commercial extract), encompassing full stabilization of its three-dimensional structure, has been attempted via nanoencapsulation within lipid nanovesicles, integrating a multiple water-in-oil-in-water emulsion. Long-term storage of the multiple nanoemulsions produced did not lead to leaching of protein, thus proving the effectiveness of the encapsulation procedure. Furthermore, lactoferrin nanovesicle derivatives prepared under optimal conditions were successfully employed at lab-scale antimicrobial trials.Financial support from Fundacao Ensino e Cultura Fernando Pessoa (FECFP, Porto, Portugal) and from Fundacao para a Ciencia e a Tecnologia (FCT, Lisbon, Portugal) as pluriannual funding, is gratefully acknowledged. Financial support to Victor M. Balcao, via an Invited Research Scientist fellowship (FAPESP Ref. No. 2011/51077-8) by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo, Brazil), is hereby gratefully acknowledged. The authors are also grateful to Dr. Madalena Vieira (affiliated with the IBB) for technical help

1 October 2017 in Process Biochemistry
Verified
Journal Article
Closed access
LRLiliam K.H. Rocha
Liliam K.H. Rocha
LFLaura I.L. Favaro
Laura I.L. Favaro
ARAlessandra C. Rios
Alessandra C. Rios
ESErica C. Silva
Erica C. Silva
WSWelida F. Silva
Welida F. Silva
VBVictor M. Balcão
Victor M. Balcão

3 October 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Stephen EmenchetaStephen Emencheta
Stephen Emencheta
COChinasa V. Olovo
Chinasa V. Olovo
OEOsita C. Eze
Osita C. Eze
CKChisom F. Kalu
Chisom F. Kalu
Dinebari Philip BerebonDinebari Philip Berebon
Dinebari Philip Berebon
AAAnthony Amaechi Attama
Anthony Amaechi Attama
Bacteriophages (phages) are nano-sized viruses characterized by their inherent ability to live off bacteria. They utilize diverse mechanisms to absorb and gain entry into the bacterial cell wall via the release of viral genetic material, which uses the replication mechanisms of the host bacteria to produce and release daughter progeny virions that attack the surrounding host cells. They possess specific characteristics, including specificity for particular or closely related bacterial species. They have many applications, including as potential alternatives to antibiotics against multi-resistant bacterial pathogens and as control agents in bacteria-contaminated environments. They are ubiquitously abundant in nature and have diverse biota, including in the gut. Gut microbiota describes the community and interactions of microorganisms within the intestine. As with bacteria, parasitic bacteriophages constantly interact with the host bacterial cells within the gut system and have obvious implications for human health. However, it is imperative to understand these interactions as they open up possible applicable techniques to control gut-implicated bacterial diseases. Thus, this review aims to explore the interactions of bacteriophages with bacterial communities in the gut and their current and potential impacts on human health.